Avadel Pharmaceuticals
0
0
+€0.00+0% 00:00 今天
統計
當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-
競爭對手
此清單為基於近期市場事件的分析。並非投資建議。
Jazz Pharmaceuticals
JAZZ
市值15.32B
Axsome Therapeutics
AXSM
市值12.03B
Heron Therapeutics
HRTX
市值78.44M
Teva- Pharmaceutical Industries
TEVA
市值38.37B
Biogen
BIIB
市值29.4B
Johnson & Johnson
JNJ
市值618.61B
Novartis
NVS
市值293.94B
Pfizer
PFE
市值137.76B
Merck
MRK
市值305.12B
關於
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Show more...
執行長
Mr. Gregory J. Divis Jr.
員工
188
國家
法國
ISIN
US05337M1045
上市
0 Comments
分享你的想法
FAQ
Avadel Pharmaceuticals 的股票代號是什麼？▼
根據交易所不同，股票代號可能會有所差異。例如，在 Boerse Stuttgart 交易所，Avadel Pharmaceuticals 的股票以代號 AWK1.STU 進行交易。
Avadel Pharmaceuticals 有多少名員工？▼
截至 July 25, 2026，公司共有 188 名員工。
Avadel Pharmaceuticals 位於哪個產業？▼
Avadel Pharmaceuticals從事於Health & Wellness產業。
Avadel Pharmaceuticals 何時完成拆股？▼
Avadel Pharmaceuticals 最近沒有進行任何拆股。
Avadel Pharmaceuticals 的總部在哪裡？▼
Avadel Pharmaceuticals 的總部位於 法國 的 Dublin。